Welcome to our dedicated page for Exela Technologi news (Ticker: XELAW), a resource for investors and traders seeking the latest updates and insights on Exela Technologi stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Exela Technologi's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Exela Technologi's position in the market.
Exela Technologies has launched a 10-year, $90 million venture utilizing its PCH Global platform to enhance digital transformation for a major US health insurance company. This marks Exela's debut in the healthcare sector, enabling large-scale deployment of its digital exchange platform for processing complex health insurance claims. The partnership builds on over $28 million in revenue in 2020, with an aim to migrate existing healthcare relationships to its cloud network, improving scalability and analytics.
On February 24, 2021, Exela Technologies (NASDAQ: XELA) announced its participation in a fireside chat at 11:00 a.m. ET, hosted by Cowen analyst Bryan Bergin. Key executives, including Chairman Par Chadha and CEO Ron Cogburn, will discuss Exela’s Bill and Payments Exchange (XBP). An archived version of the chat and presentation slides will be available on the Company’s website for a limited time. Exela, a leader in business process automation, serves over 4,000 customers in 50 countries, including a substantial number of Fortune 100 companies.
Exela Technologies (NASDAQ: XELA) has launched the IntelliScan Raptor scanner, a high-speed scanning solution capable of processing up to 240 pages per minute. The Raptor is designed for mid to high volume document handling, making it suitable for various sectors including banking and healthcare. It combines affordability, superior image quality, and flexible paper handling. Manufactured in the US and Asia, Exela plans to support the Raptor through its global service organizations and reseller partners, enhancing its document digitization offerings.
Exela Technologies, Inc. (NASDAQ: XELA) announced on February 10, 2021, that it has regained compliance with the minimum bid price requirement set by Nasdaq, following a letter received on February 9, 2021. This compliance is crucial for maintaining its listing on the exchange. Exela, a leader in business process automation, serves over 4,000 clients in 50 countries, providing integrated technology and operations solutions across various industries.
Exela Technologies (NASDAQ: XELA) received an extension from the Nasdaq Hearings Panel to meet the $1.00 bid price requirement for continued listing. The Company must maintain a closing bid price of at least $1.00 for ten consecutive business days by February 8, 2021. Exela faced a compliance issue and requested a hearing, which resulted in the extension. CEO Ronald Cogburn expressed optimism about the Company’s progress and initiatives, including partnerships with Mastercard/Vocalink and new customer acquisitions.
Exela Technologies announced a new contract worth $15.6 million with a leading health organization for payment and explanation of benefits processing, starting in Q4 2020. This contract highlights Exela's innovative PCH Global solution, designed to improve payment processing efficiency and customer experience.